$INSM Recent Headlines Arikace gets FDA fast-tra
Post# of 94144
Posted On: 12/11/2013 2:04:35 PM
$INSM Recent Headlines
Arikace gets FDA fast-tracks for lung treatments 6:48 a.m. July 1, 2013 - MarketWatch.com
Insiders have been buying these stocks 11:51 a.m. Jan. 14, 2013 - Insider Monkey
Insmed to sell 6.3 mln shares to investment firms 10:25 a.m. Sept. 28, 2012 - MarketWatch.com
Insmed rockets on FDA update 9:45 a.m. May 7, 2012 - Val Brickates Kennedy
Insmed: FDA lifts halt on lung-disease-drug trial 9:02 a.m. Jan. 20, 2012 - MarketWatch.com
Stocks to Watch Tuesday: Netflix, Insmed 3:28 p.m. Oct. 10, 2011 - David B. Wilkerson
Monday’s biggest gaining & declining stocks 12:06 p.m. Oct. 10, 2011 - Sue Chang
Insmed: FDA extends halt to study, seeks more data 8:25 a.m. Oct. 10, 2011 - MarketWatch.com
Insmed tanks on FDA study halt 1:13 p.m. Aug. 2, 2011 - Val Brickates Kennedy
FDA halts Inmed study after rat tests 9:19 a.m. Aug. 2, 2011 - MarketWatch.com
9 Biotechnology Stocks to Buy Now 6:00 a.m. Today - InvestorPlace.com
7 Biotechnology Stocks to Buy Now 6:30 a.m. Dec. 4, 2013 - InvestorPlace.com
Short Interest Expands By 13.2% For INSM 4:02 p.m. Nov. 27, 2013 - TheStreet.com
UPDATE: Piper Jaffray Initiates Coverage on Insmed as 2014 Biotech Sector Outlook Remains Strong 9:48 a.m. Nov. 27, 2013 - benzinga.com
Healthcare coverage initiations roundup 8:55 a.m. Nov. 27, 2013 - Seeking Alpha
5 Biotechnology Stocks to Buy Now 7:00 a.m. Nov. 27, 2013 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 6:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Use Options For A Chance To Buy INSM At A 48% Discount 12:29 p.m. Nov. 13, 2013 - TheStreet.com
7 Biotechnology Stocks to Buy Now 5:00 a.m. Nov. 13, 2013 - InvestorPlace.com
6 Biotechnology Stocks to Buy Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
Insmed Incorporated Management Discusses Q3 2013 Results - Earnings Call Transcript 7:10 p.m. Nov. 5, 2013 - Seeking Alpha
Insmed, Inc. Discusses Q3 2013 Results (Webcast) 8:25 a.m. Nov. 5, 2013 - Seeking Alpha
10-Q: INSMED INC 7:32 a.m. Nov. 5, 2013 - Edgar Online - (EDG = 10Q, 10K)
7 Biotechnology Stocks to Buy Now 6:15 a.m. Oct. 30, 2013 - InvestorPlace.com
Insmed Stock Sees Short Interest Decline 43.8% 3:39 p.m. Oct. 25, 2013 - TheStreet.com
First Week Of INSM December 21st Options Trading 11:10 a.m. Oct. 23, 2013 - TheStreet.com
6 Biotechnology Stocks to Buy Now 6:45 a.m. Oct. 23, 2013 - InvestorPlace.com
Problems Found With Insmed's Analysis of Arikace Cystic Fibrosis Study 7:43 a.m. Oct. 22, 2013 - TheStreet.com
Insmed's Arikace Makes Progress - Analyst Blog 5:00 p.m. Oct. 16, 2013 - Zacks.com
6 Biotechnology Stocks to Buy Now 5:45 a.m. Oct. 16, 2013 - InvestorPlace.com
Daily Trends Scanner: BioMarin Pharma Inc., Delcath Systems Inc., Akorn Inc., and Insmed Inc. 10:19 a.m. Today - PR Newswire
Healthcare Companies Report Appointments, Phase 1 Studies, and Corporate Growth - Research Report on HCA, Isis Pharmaceuticals, Oxygen Biotherapeutics, Insmed, and Zalicus 8:00 a.m. Dec. 3, 2013 - PR Newswire
Financial Results, Conference Calls Schedules, and Outlook- Research Report on Spectrum, Magellan, Insmed, GenMark, and Envision 8:00 a.m. Nov. 18, 2013 - PR Newswire
Pre-Market Review: Delcath Systems Inc., BioMarin Pharma Inc., Insmed Inc., and Akorn Inc. 8:00 a.m. Nov. 15, 2013 - PR Newswire
Closing of Over-Allotment Options, Receiving Orphan Drug Designations, Release of Clinical Data, and Obtaining Important Patents - Research Report on Galena, Zalicus, Infinity, Stemline and Insmed 8:00 a.m. Nov. 5, 2013 - PR Newswire
Insmed Reports Third Quarter 2013 Financial Results 7:30 a.m. Nov. 5, 2013 - Marketwire
Insmed Appoints David W.J. McGirr to Its Board of Directors 7:01 a.m. Nov. 1, 2013 - Marketwire
Pre-Market Analysis: BioMarin Pharma Inc., Insmed Inc., Delcath Systems Inc., and Akorn Inc. 10:34 a.m. Oct. 25, 2013 - PR Newswire
Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros 7:00 a.m. Oct. 21, 2013 - PR Newswire
Insmed Completes Enrollment of Phase 2 Clinical Trial of ARIKACE to Treat Nontuberculous Mycobacteria Lung Disease in U.S. and Canada 7:03 a.m. Oct. 15, 2013 - Marketwire
Insmed to Present at Leerink Swann Rare Disease Roundtable 7:31 a.m. Sept. 25, 2013 - Marketwire
Insmed Fortifies Global Patent Portfolio 6:31 a.m. Sept. 11, 2013 - Marketwire
Insmed to Participate in the Stifel Healthcare Conference 2013 7:01 a.m. Sept. 4, 2013 - Marketwire
Biotech Firms Announce Financial Results, Resignations, Reintroduce Treatments and Receive Reviews on Key Products - Research Report on Insmed, ImmunoGen, VIVUS, Theravance, and XOMA 7:00 a.m. Sept. 3, 2013 - PR Newswire
Insmed to Participate in August Investor Conferences 8:02 a.m. Aug. 7, 2013 - Marketwire
Insmed Reports Second Quarter Financial Results 6:31 a.m. Aug. 6, 2013 - Marketwire
Insmed to Host Second Quarter 2013 Financial Results Conference Call on Tuesday, August 6, 2013 7:31 a.m. July 31, 2013 - Marketwire
Insmed Appoints Christine Pellizzari as General Counsel and Corporate Secretary 8:37 a.m. July 29, 2013 - Marketwire
Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares 9:58 a.m. July 22, 2013 - Marketwire
Insmed Announces Pricing of Public Offering of Common Stock 7:02 a.m. July 17, 2013 - Marketwire
Arikace gets FDA fast-tracks for lung treatments 6:48 a.m. July 1, 2013 - MarketWatch.com
Insiders have been buying these stocks 11:51 a.m. Jan. 14, 2013 - Insider Monkey
Insmed to sell 6.3 mln shares to investment firms 10:25 a.m. Sept. 28, 2012 - MarketWatch.com
Insmed rockets on FDA update 9:45 a.m. May 7, 2012 - Val Brickates Kennedy
Insmed: FDA lifts halt on lung-disease-drug trial 9:02 a.m. Jan. 20, 2012 - MarketWatch.com
Stocks to Watch Tuesday: Netflix, Insmed 3:28 p.m. Oct. 10, 2011 - David B. Wilkerson
Monday’s biggest gaining & declining stocks 12:06 p.m. Oct. 10, 2011 - Sue Chang
Insmed: FDA extends halt to study, seeks more data 8:25 a.m. Oct. 10, 2011 - MarketWatch.com
Insmed tanks on FDA study halt 1:13 p.m. Aug. 2, 2011 - Val Brickates Kennedy
FDA halts Inmed study after rat tests 9:19 a.m. Aug. 2, 2011 - MarketWatch.com
9 Biotechnology Stocks to Buy Now 6:00 a.m. Today - InvestorPlace.com
7 Biotechnology Stocks to Buy Now 6:30 a.m. Dec. 4, 2013 - InvestorPlace.com
Short Interest Expands By 13.2% For INSM 4:02 p.m. Nov. 27, 2013 - TheStreet.com
UPDATE: Piper Jaffray Initiates Coverage on Insmed as 2014 Biotech Sector Outlook Remains Strong 9:48 a.m. Nov. 27, 2013 - benzinga.com
Healthcare coverage initiations roundup 8:55 a.m. Nov. 27, 2013 - Seeking Alpha
5 Biotechnology Stocks to Buy Now 7:00 a.m. Nov. 27, 2013 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 6:45 a.m. Nov. 20, 2013 - InvestorPlace.com
Use Options For A Chance To Buy INSM At A 48% Discount 12:29 p.m. Nov. 13, 2013 - TheStreet.com
7 Biotechnology Stocks to Buy Now 5:00 a.m. Nov. 13, 2013 - InvestorPlace.com
6 Biotechnology Stocks to Buy Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
Insmed Incorporated Management Discusses Q3 2013 Results - Earnings Call Transcript 7:10 p.m. Nov. 5, 2013 - Seeking Alpha
Insmed, Inc. Discusses Q3 2013 Results (Webcast) 8:25 a.m. Nov. 5, 2013 - Seeking Alpha
10-Q: INSMED INC 7:32 a.m. Nov. 5, 2013 - Edgar Online - (EDG = 10Q, 10K)
7 Biotechnology Stocks to Buy Now 6:15 a.m. Oct. 30, 2013 - InvestorPlace.com
Insmed Stock Sees Short Interest Decline 43.8% 3:39 p.m. Oct. 25, 2013 - TheStreet.com
First Week Of INSM December 21st Options Trading 11:10 a.m. Oct. 23, 2013 - TheStreet.com
6 Biotechnology Stocks to Buy Now 6:45 a.m. Oct. 23, 2013 - InvestorPlace.com
Problems Found With Insmed's Analysis of Arikace Cystic Fibrosis Study 7:43 a.m. Oct. 22, 2013 - TheStreet.com
Insmed's Arikace Makes Progress - Analyst Blog 5:00 p.m. Oct. 16, 2013 - Zacks.com
6 Biotechnology Stocks to Buy Now 5:45 a.m. Oct. 16, 2013 - InvestorPlace.com
Daily Trends Scanner: BioMarin Pharma Inc., Delcath Systems Inc., Akorn Inc., and Insmed Inc. 10:19 a.m. Today - PR Newswire
Healthcare Companies Report Appointments, Phase 1 Studies, and Corporate Growth - Research Report on HCA, Isis Pharmaceuticals, Oxygen Biotherapeutics, Insmed, and Zalicus 8:00 a.m. Dec. 3, 2013 - PR Newswire
Financial Results, Conference Calls Schedules, and Outlook- Research Report on Spectrum, Magellan, Insmed, GenMark, and Envision 8:00 a.m. Nov. 18, 2013 - PR Newswire
Pre-Market Review: Delcath Systems Inc., BioMarin Pharma Inc., Insmed Inc., and Akorn Inc. 8:00 a.m. Nov. 15, 2013 - PR Newswire
Closing of Over-Allotment Options, Receiving Orphan Drug Designations, Release of Clinical Data, and Obtaining Important Patents - Research Report on Galena, Zalicus, Infinity, Stemline and Insmed 8:00 a.m. Nov. 5, 2013 - PR Newswire
Insmed Reports Third Quarter 2013 Financial Results 7:30 a.m. Nov. 5, 2013 - Marketwire
Insmed Appoints David W.J. McGirr to Its Board of Directors 7:01 a.m. Nov. 1, 2013 - Marketwire
Pre-Market Analysis: BioMarin Pharma Inc., Insmed Inc., Delcath Systems Inc., and Akorn Inc. 10:34 a.m. Oct. 25, 2013 - PR Newswire
Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros 7:00 a.m. Oct. 21, 2013 - PR Newswire
Insmed Completes Enrollment of Phase 2 Clinical Trial of ARIKACE to Treat Nontuberculous Mycobacteria Lung Disease in U.S. and Canada 7:03 a.m. Oct. 15, 2013 - Marketwire
Insmed to Present at Leerink Swann Rare Disease Roundtable 7:31 a.m. Sept. 25, 2013 - Marketwire
Insmed Fortifies Global Patent Portfolio 6:31 a.m. Sept. 11, 2013 - Marketwire
Insmed to Participate in the Stifel Healthcare Conference 2013 7:01 a.m. Sept. 4, 2013 - Marketwire
Biotech Firms Announce Financial Results, Resignations, Reintroduce Treatments and Receive Reviews on Key Products - Research Report on Insmed, ImmunoGen, VIVUS, Theravance, and XOMA 7:00 a.m. Sept. 3, 2013 - PR Newswire
Insmed to Participate in August Investor Conferences 8:02 a.m. Aug. 7, 2013 - Marketwire
Insmed Reports Second Quarter Financial Results 6:31 a.m. Aug. 6, 2013 - Marketwire
Insmed to Host Second Quarter 2013 Financial Results Conference Call on Tuesday, August 6, 2013 7:31 a.m. July 31, 2013 - Marketwire
Insmed Appoints Christine Pellizzari as General Counsel and Corporate Secretary 8:37 a.m. July 29, 2013 - Marketwire
Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares 9:58 a.m. July 22, 2013 - Marketwire
Insmed Announces Pricing of Public Offering of Common Stock 7:02 a.m. July 17, 2013 - Marketwire
(0)
(0)Scroll down for more posts ▼